Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
December 8, 2025BloodOpen Access

Prognostic relevance of epigenetic regulation of drug pharmacology and myeloid genes in pediatric AML

View Full Paper
Ask AI
Bookmark
Share

Authors

FMFrancisco MarchiXCXueyuan CaoJRJeffrey E. Rubnitz

Discussion

Loading...

Member takes

Overview

Observational analysis shows that DNA methylation affects treatment outcomes in pediatric AML, indicating potential for targeted therapies.

Key Points

  • Higher levels of DNA methylation in key genes correlate with worse overall survival in pediatric acute myeloid leukemia patients.
  • This study validated associations between gene expression, methylation levels, and clinical outcomes in two independent cohorts.
  • Cox proportional hazard analysis identified significant CpGs linked to event-free survival and overall survival.
  • The findings support the potential of hypomethylating agents to enhance outcomes in acute myeloid leukemia.

Cite This Study

Marchi et al. (2025) studied this question.

synapsesocial.com/papers/69362f364fa91c937236d32fhttps://doi.org/10.1182/blood-2025-1712
View Full Paper
Ask AI
Bookmark
Share